| 查看: 136 | 回复: 0 | |||
| 当前主题已经存档。 | |||
lxl8506铜虫 (正式写手)
|
[交流]
800金英译中文章"多酸被证为纳摩尔非竞争性的蛋白激酶CK2抑制剂"23日止
|
||
|
题目:Identification of Polyoxometalates as Nanomolar Noncompetitive Inhibitors of Protein Kinase CK2 Summary Protein kinase CK2 is a multifunctional kinase of medical importance that is dysregulated in many cancers. In this study, polyoxometalates were identified as original CK2 inhibitors. [P2Mo18O62]6− has the most potent activity. It inhibits the kinase in the nanomolar range by targeting key structural elements located outside the ATP- and peptide substrate-binding sites. Several polyoxometalate derivatives exhibit strong inhibitory efficiency, with IC50 values ≤ 10 nM. Furthermore, these inorganic compounds show a striking specificity for CK2 when tested in a panel of 29 kinases. Therefore, polyoxometalates are effective CK2 inhibitors in terms of both efficiency and selectivity and represent nonclassical kinase inhibitors that interact with CK2 in a unique way. This binding mode may provide an exploitable mechanism for developing potent drugs with desirable properties, such as enhanced selectivity relative to ATP-mimetic inhibitors. PDF图文表共730KB 但总是传不上 联系lxl8506@sina.com 谢谢了 |
回复此楼» 猜你喜欢
之前让一硕士生水了7个发明专利，现在这7个获批发明专利的维护费可从哪儿支出哈？
已经有9人回复
-
心脉受损
已经有6人回复
-
博士申请都是内定的吗？
已经有8人回复
-
博士读完未来一定会好吗
已经有32人回复
-
读博
已经有5人回复
-
投稿精细化工
已经有4人回复
-
高职单位投计算机相关的北核或SCI四区期刊推荐，求支招！
已经有4人回复
-
导师想让我从独立一作变成了共一第一
已经有9人回复
-
Springer期刊投稿求助
已经有4人回复
